"Herpesvirus 1, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of SIMPLEXVIRUS causing most forms of non-genital herpes simplex in humans. Primary infection occurs mainly in infants and young children and then the virus becomes latent in the dorsal root ganglion. It then is periodically reactivated throughout life causing mostly benign conditions.
| Descriptor ID |
D018259
|
| MeSH Number(s) |
B04.280.382.100.750.390
|
| Concept/Terms |
Herpesvirus 1, Human- Herpesvirus 1, Human
- Herpesvirus 1 (alpha), Human
- Human Herpesvirus 1
- HHV-1
- Herpes Simplex Virus Type 1
- Herpes Simplex Virus 1
- HSV-1
|
Below are MeSH descriptors whose meaning is more general than "Herpesvirus 1, Human".
Below are MeSH descriptors whose meaning is more specific than "Herpesvirus 1, Human".
This graph shows the total number of publications written about "Herpesvirus 1, Human" by people in this website by year, and whether "Herpesvirus 1, Human" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 1 | 4 |
| 1996 | 5 | 0 | 5 |
| 1997 | 5 | 0 | 5 |
| 1998 | 3 | 0 | 3 |
| 1999 | 3 | 0 | 3 |
| 2000 | 12 | 0 | 12 |
| 2001 | 13 | 2 | 15 |
| 2002 | 14 | 0 | 14 |
| 2003 | 11 | 0 | 11 |
| 2004 | 9 | 4 | 13 |
| 2005 | 8 | 1 | 9 |
| 2006 | 14 | 1 | 15 |
| 2007 | 10 | 1 | 11 |
| 2008 | 6 | 0 | 6 |
| 2009 | 4 | 2 | 6 |
| 2010 | 7 | 1 | 8 |
| 2011 | 6 | 0 | 6 |
| 2012 | 3 | 0 | 3 |
| 2013 | 10 | 1 | 11 |
| 2014 | 6 | 1 | 7 |
| 2015 | 4 | 1 | 5 |
| 2016 | 3 | 0 | 3 |
| 2017 | 0 | 1 | 1 |
| 2018 | 3 | 0 | 3 |
| 2019 | 4 | 1 | 5 |
| 2020 | 1 | 1 | 2 |
| 2021 | 2 | 0 | 2 |
| 2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Herpesvirus 1, Human" by people in Profiles.
-
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma. J Clin Oncol. 2023 01 20; 41(3):528-540.
-
Gastric herpes simplex virus type 1 infection is associated with functional gastrointestinal disorders in the presence and absence of comorbid fibromyalgia: a pilot case-control study. Infection. 2022 Oct; 50(5):1303-1311.
-
The US3 Kinase of Herpes Simplex Virus Phosphorylates the RNA Sensor RIG-I To Suppress Innate Immunity. J Virol. 2022 02 23; 96(4):e0151021.
-
Herpesvirus-mediated stabilization of ICP0 expression neutralizes restriction by TRIM23. Proc Natl Acad Sci U S A. 2021 12 21; 118(51).
-
Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice. Viruses. 2021 07 22; 13(8).
-
The herpesvirus accessory protein ?134.5 facilitates viral replication by disabling mitochondrial translocation of RIG-I. PLoS Pathog. 2021 03; 17(3):e1009446.
-
Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice. Viruses. 2021 Jan 09; 13(1).
-
Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study. Clin Cancer Res. 2020 10 01; 26(19):5153-5161.
-
hnRNPA2B1 Associated with Recruitment of RNA into Exosomes Plays a Key Role in Herpes Simplex Virus 1 Release from Infected Cells. J Virol. 2020 06 16; 94(13).
-
Herpes Simplex Virus 1 MicroRNA miR-H28 Exported to Uninfected Cells in Exosomes Restricts Cell-to-Cell Virus Spread by Inducing Gamma Interferon mRNA. J Virol. 2019 11 01; 93(21).